We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Studies have showed using TriageHF reduced all-cause hospitalisations by 58% according to Ahmed et al. (2024). Using ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

This page provides a summary of the findings from the report. It includes insight from Kay Boycott, chief executive of the Asthma UK and British Lung Foundation Partnership, about NICE's role in ...

This page provides a summary of the findings from the report. It includes insight from Dr John Graham, consultant oncologist and cancer lead clinician at Taunton and Somerset NHS Foundation Trust, ...

The HTA Lab enables NICE to develop creative solutions to complex problems in health technology assessment. It offers a ‘safe space’ for creating solutions in collaboration with system partners and ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

All NICE products on lipid disorders. Includes any guidance and quality standards.

Public involvement is a vital part of the way we work. Our Public Involvement Programme develops and supports the involvement of people who use services, carers and members of the public, along with ...

How has our guidance been used in practice? NICE impact reports review how our guidance is used to improve the health and care of people. We base the reports on data from national audits, reports, ...

All forms of inflammatory arthritis have similar management strategies coordinated through a multidisciplinary team. Pharmacological treatments are prescribed to relieve painful symptoms and to slow ...